Venetoclax enhances DNA damage induced by XPO1 inhibitors: A novel mechanism underlying the synergistic antileukaemic effect in acute myeloid leukaemia
出版年份 2022 全文链接
标题
Venetoclax enhances DNA damage induced by XPO1 inhibitors: A novel mechanism underlying the synergistic antileukaemic effect in acute myeloid leukaemia
作者
关键词
-
出版物
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 26, Issue 9, Pages 2646-2657
出版商
Wiley
发表日期
2022-03-31
DOI
10.1111/jcmm.17274
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML
- (2021) Xinan Qiao et al. Blood Cancer Journal
- Selinexor for the treatment of multiple myeloma
- (2020) Klaus Podar et al. EXPERT OPINION ON PHARMACOTHERAPY
- CUDC‐907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of action
- (2020) Cheng Hu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia
- (2019) Xinyu Li et al. HAEMATOLOGICA
- Venetoclax-based Therapies for Acute Myeloid Leukemia
- (2019) Veronica A. Guerra et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex Vivo
- (2019) Fangbing Liu et al. Targeted Oncology
- Selinexor: First Global Approval
- (2019) Yahiya Y. Syed DRUGS
- MYC protein expression is an important prognostic factor in acute myeloid leukemia
- (2018) Maro Ohanian et al. LEUKEMIA & LYMPHOMA
- Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents
- (2018) Trinayan Kashyap et al. Oncotarget
- Inhibition of XPO1 enhances cell death induced by ABT-199 in acute myeloid leukaemia via Mcl-1
- (2018) Daniel A. Luedtke et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- DNA damage response and hematological malignancy
- (2017) Masatoshi Takagi INTERNATIONAL JOURNAL OF HEMATOLOGY
- A Critical Balance: dNTPs and the Maintenance of Genome Stability
- (2017) Chen‐Chun Pai et al. Genes
- The Second-Generation Exportin-1 Inhibitor KPT-8602 Demonstrates Potent Activity against Acute Lymphoblastic Leukemia
- (2016) Thomas Vercruysse et al. CLINICAL CANCER RESEARCH
- XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase II to the Nucleus
- (2016) P. Ranganathan et al. CLINICAL CANCER RESEARCH
- KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells
- (2016) J Etchin et al. LEUKEMIA
- Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies
- (2016) Z A Hing et al. LEUKEMIA
- Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase
- (2015) Rémi Buisson et al. MOLECULAR CELL
- KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma
- (2014) Yun Zheng et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Obatoclax potentiates the cytotoxic effect of cytarabine on acute myeloid leukemia cells by enhancing DNA damage
- (2014) Chengzhi Xie et al. Molecular Oncology
- Selective inhibitors of nuclear export for the treatment of non-Hodgkin's lymphomas
- (2013) A. S. Azmi et al. HAEMATOLOGICA
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia
- (2012) P. Ranganathan et al. BLOOD
- MYC oncogene in myeloid neoplasias
- (2012) M. Dolores Delgado et al. Clinical & Translational Oncology
- Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells
- (2012) J Etchin et al. LEUKEMIA
- NESdb: a database of NES-containing CRM1 cargoes
- (2012) Darui Xu et al. MOLECULAR BIOLOGY OF THE CELL
- Histone H2AX and Poly(ADP-Ribose) as Clinical Pharmacodynamic Biomarkers
- (2010) C. E. Redon et al. CLINICAL CANCER RESEARCH
- Recognition of nuclear targeting signals by Karyopherin-β proteins
- (2010) Darui Xu et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Anti-apoptotic Protein BCL2 Down-regulates DNA End Joining in Cancer Cells
- (2010) Tadi Satish Kumar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Myc Is Required for Activation of the ATM-Dependent Checkpoints in Response to DNA Damage
- (2010) Lina Guerra et al. PLoS One
- A Bifunctional Regulatory Element in Human Somatic Wee1 Mediates Cyclin A/Cdk2 Binding and Crm1-Dependent Nuclear Export
- (2009) C. Li et al. MOLECULAR AND CELLULAR BIOLOGY
- Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer
- (2008) Aurelia Noske et al. CANCER
- The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation
- (2008) Pauline J. van der Watt et al. INTERNATIONAL JOURNAL OF CANCER
- Transcription-independent functions of MYC: regulation of translation and DNA replication
- (2008) Michael D. Cole et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started